Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Unilabs, Ambry Genetics Partner to Market Research-Use Genomic Testing Services Internationally
The companies aim to offer genetic testing for biopharma and government-sponsored research in Europe, Latin America, and the Middle East.
Japanese Lung Cancer Genomic Screening Project Expands in Asia-Pacific
LC-SCRUM-Asia, a genomic screening project and database that initially launched in Japan in 2013, is expanding and will cover additional countries in the Asia-Pacific region.
Centogene Gets Nasdaq Non-Compliance Notice
The company has 180 days from the date of the notice to regain compliance with the listing requirement, during which time it will continue to trade on the exchange.
Drug, Diagnostic Developer HMNC Brain Health Raises €14.3M
The German company is developing drugs and companion diagnostics for a range of psychiatric conditions including major depressive disorder.
The company wants to commercialize its first antidepressant-matching service in 2023 and is hoping to launch it as an LDT in the US.